ExL Pharma Proudly Presents
2nd Quality Oversight of Clinical Vendors
Strategies for Assessing and Managing Quality at CROs and other Specialty Providers
October 17-19, 2011 | Westin Arlington Gateway | Arlington, VA
Scroll Down for Choose from two pre-conference interactive workshops:
WORKSHOP A – ADVANCED VENDOR OVERSIGHT: QUALITY OVERSIGHT & QUALITY MANAGEMENT
How to Develop, Implement and Execute an Effective, Risk-Based Vendor Quality Management Plan
Liz Wool, CCRA, CMT, President & CEO, QD-QUALITY AND TRAINING SOLUTIONS, INC. Member, Board of Trustees, ASSOCIATION OF CLINICAL RESEARCH PROFESSIONALS (ACRP)
WORKSHOP B – CLINICAL MONITORING
Strategies for Identifying, Overseeing and Administering New and Effective Clinical Monitoring Models
Eileen DiRita, GCP Compliance Manager, ENDO PHARMACEUTICALS
Richard Reeve, Senior Director, QA, ENDO PHARMACEUTICALS
Sharon Reinhard, Associate Director, Clinical QC, ENDO PHARMACEUTICALS
Attend the Conference to Receive a FREE Copy of the Executive Summary of Avoca Group's 2011 Survey on Reducing Micro-Management of CROs While Maintaining Effective Quality Oversight, Results from over 280 Sponsor & Service Providers. |
 Join our LinkedIn group to network and interact with other GCP Professionals – Proactive GCP Compliance
|
The 2nd Quality Oversight of Clinical Vendors Conference is just around the corner, taking place October 17-19 at the Westin in Arlington, VA. Register now and join the almost 100 senior-level clinical quality and compliance professionals expected to attend including representatives from the following companies:
ACM Global Central Laboratory
|
Acucela Inc
|
Advance Research Associates
|
Aeras
|
Agensys
|
AMAG Pharmaceuticals, Inc.
|
AstraZeneca
|
Beaufort LLC
|
Bristol-Myers Squibb
|
Celgene Corp.
|
Cephalon, Inc.
|
ClinAudits
|
Compliance Implementation Services
|
Cubist Pharmaceuticals, Inc.
|
Eli Lilly
|
Endo Pharmaceuticals
|
Endocyte
|
Falcon Group
|
Fibrogen
|
Forest Laboratories, Inc.
|
Hospira, Inc.
|
ICON Clinical Research
|
ImClone
|
Janssen Pharmaceutica NV
|
Johnson & Johnson
|
Johnson and Johnson Consumer and Personal Products Worldwide
|
Johnson and Johnson Consumer Products Worldwide
|
Kforce Clinical Research
|
Kyowa Hakko Kirin Pharma Inc.
|
LEO Pharma
|
Lung Rx
|
MacroGenics
|
Medtronic
|
Metrics Champion Consortium
|
Millennium Pharmaceuticals, Inc.
|
Mylan Pharmaceuticals Inc.
|
PharmaNet
|
PHT Corporation
|
POZEN Inc.
|
QD-Quality and Training Solutions, Inc.
|
Regeneron Pharmaceuticals Inc.
|
Regulatory Risk Management, LLC
|
ReSearch Pharmaceutical Services, Inc.
|
Roche
|
RPS
|
Shire
|
Takeda Global Research & Development Center, Inc.
|
The Avoca Group, Inc
|
The Weinberg Group
|
UCB Biosciences, Inc
|
ViroPharma Incorporated
|
Warner Chilcott
|
|
|
|
The expert speaking faculty present case studies, best practices and lessons learned from their experiences on such topics as:
- CLINICAL MONITORING: Case Study Examples of Clinical Monitoring Oversight from an Auditor's Perspective
- QUALITY METRICS: Defining, Implementing and Tracking Quality Metrics to Effectively Oversee Vendor Performance and Clinical Conduct
- COMMUNICATION OPTIMIZATION: Establishing Internal and External Communication Plans to Facilitate Effective Oversight
- QUALITY MANAGEMENT PLAN: Sponsor-CRO Quality Management Plans: An Integrated Approach to Building Relationships, Increasing Transparency and Ensuring Quality
- IN-PROCESS AUDIT STRATEGY: Effectively Gauging a Vendor’s Performance and Verifying Compliance by Auditing Ongoing Work Streams
- VENDOR QUALIFICATION: Strategies for Effective Risk Assessment when Selecting a Vendor
- LEGAL PERSPECTIVE: An Overview of Issued FDA Warning Letters: What Happened and What Can be Learned
Please Use Promo Code: P1311ACT
Questions? Comments? Contact Kristen Hunter at khunter@exlpharma.com
For more information on the available sponsoring and exhibiting opportunities, please contact Mark Coulter at 917-258-5140 or mcoulter@exlpharma.com.
|